![[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients](https://i1.wp.com/ml-eu.globenewswire.com/media/NTJlMDkyZjktNGMwNi00N2YyLTkyZmQtZTIwMWJlNzgxOWYyLTEwMTI2MjEtMjAyNS0wNi0xNS1lbg==/tiny/F-Hoffmann-La-Roche-Ltd.png?w=150&resize=150,150&ssl=1 "[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients")
Automation Anywhere Reports Strong Q1 Fiscal Year 2026 Growth and Profitability, Driven by Increased Demand for the Agentic Process Automation System
At Imagine 2025, Automation Anywhere Extended its Lead in AI Innovation with…
Gastops and Leeway Marine Advance Innovative Engine Oil Monitoring System with Successful Field Testing
DARTMOUTH, NS, May 26, 2025 /PRNewswire/ -- Gastops is pleased to announce…
Biometric passport for the DR Congo – implemented with DERMALOG as system partner
The Democratic Republic of the Congo officially introduced its new biometric passport…
